Advertisement
Advertisement
Eton Pharmaceuticals Reports Robust Q2 2025 Growth
PremiumCompany AnnouncementsEton Pharmaceuticals Reports Robust Q2 2025 Growth
3M ago
Eton Pharmaceuticals reports Q2 non-GAAP EPS 3c, consensus 2c
Premium
The Fly
Eton Pharmaceuticals reports Q2 non-GAAP EPS 3c, consensus 2c
3M ago
Eton Pharmaceuticals sees reaching annual revenue run rate of $80M in Q3
Premium
The Fly
Eton Pharmaceuticals sees reaching annual revenue run rate of $80M in Q3
3M ago
Eton Pharmaceuticals Joins Russell 3000 and 2000 Indexes
PremiumCompany AnnouncementsEton Pharmaceuticals Joins Russell 3000 and 2000 Indexes
5M ago
Eton Pharmaceuticals to be added to Russell 2000, Russell 3000 Indexes
Premium
The Fly
Eton Pharmaceuticals to be added to Russell 2000, Russell 3000 Indexes
5M ago
Eton Pharmaceuticals Holds Annual Stockholders Meeting
Premium
Company Announcements
Eton Pharmaceuticals Holds Annual Stockholders Meeting
5M ago
Eton Pharmaceuticals price target raised to $26 from $24 at B. Riley
PremiumThe FlyEton Pharmaceuticals price target raised to $26 from $24 at B. Riley
6M ago
Eton Pharmaceuticals’ Earnings Call: Growth and Prospects
Premium
Company Announcements
Eton Pharmaceuticals’ Earnings Call: Growth and Prospects
6M ago
Eton Pharmaceuticals price target raised to $28 from $26 at Craig-Hallum
Premium
The Fly
Eton Pharmaceuticals price target raised to $28 from $26 at Craig-Hallum
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100